ロード中...
MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation
MDL-12330A is a widely used adenylyl cyclase (AC) inhibitor that blocks AC/cAMP signaling. In this study, we demonstrated a novel antitumor activity of this drug in gastric carcinoma (GC) cell lines. In these GC cells, MDL-12330A reduced cell viability and induced cell death in a concentration-depen...
保存先:
| 出版年: | Korean J Physiol Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Physiological Society and The Korean Society of Pharmacology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507778/ https://ncbi.nlm.nih.gov/pubmed/28706453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2017.21.4.397 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|